RELA and breast cancer: To evaluate the role of NF-κB/p65 in the regulation of the malignant potential of breast cancer cells, the cells were treated with DHMEQ (10 μg/ml), and wound healing migration and Matrigel transwell invasion assays were subsequently conducted.